申请人:Salzman Andrew Lurie
公开号:US20130116284A1
公开(公告)日:2013-05-09
Provided are bifunctional compounds comprising a poly(ADP-ribose) polymerase (PARP) inhibitor moiety and a reactive oxygen species (ROS) scavenger moiety, more particularly, a lipoic acid or cyclic nitroxide derivative, covalently attached either directly or via a linker, as well as pharmaceutical compositions comprising them. The compounds and pharmaceutical compositions are useful for prevention, treatment, or management of diseases, disorders and conditions associated with elevated PARP activity or expression.
提供的是双功能化合物,包括聚(ADP-核糖)聚合酶(PARP)抑制剂基团和反应性氧自由基(ROS)清除剂基团,更具体地说,是硫辛酸或环状亚硝基衍生物,直接或通过连接剂共价连接,以及包含它们的制药组合物。这些化合物和制药组合物对于预防、治疗或管理与提高的PARP活性或表达相关的疾病、疾病和病况是有用的。